Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Problematic Medication With Benzodiazepines, "Z-drugs", and Opioid Analgesics.

Buth S, Holzbach R, Martens MS, Neumann-Runde E, Meiners O, Verthein U.

Dtsch Arztebl Int. 2019 Sep 13;116(37):607-614. doi: 10.3238/arztebl.2019.0607.

2.

Feasibility of alcohol screening and brief intervention in primary health care in Kazakhstan: study protocol of a pilot cluster randomised trial.

Schulte B, O'Donnell A, Lahusen H, Lindemann C, Prilutskaya M, Yussopov O, Kaliyeva Z, Martens MS, Verthein U.

Pilot Feasibility Stud. 2020 Jan 9;6:3. doi: 10.1186/s40814-019-0547-x. eCollection 2020.

3.

Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.

Martens MS, Zurhold H, Rosenkranz M, O'Donnell A, Addison M, Spencer L, McGovern W, Gabrhelík R, Petruželka B, Rowicka M, Liebregts N, Degkwitz P, Kaner E, Verthein U.

Harm Reduct J. 2020 Jan 13;17(1):8. doi: 10.1186/s12954-019-0339-x.

4.

The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study.

Manthey J, Lindemann C, Kraus L, Reimer J, Verthein U, Schulte B, Rehm J.

Subst Abuse Treat Prev Policy. 2020 Jan 2;15(1):1. doi: 10.1186/s13011-019-0249-7.

5.

[Provision of healthcare for people with risky alcohol use and severe alcohol use disorders in the state of Bremen, Germany: demand and guideline concordance?]

Manthey J, Lindemann C, Verthein U, Frischknecht U, Kraus L, Reimer J, Grün A, Kiefer F, Schulte B, Rehm J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):122-130. doi: 10.1007/s00103-019-03072-z. German.

PMID:
31828370
6.

Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study.

Schulte B, Schmidt CS, Strada L, Rosenkranz M, Schäfer I, Verthein U, Reimer J.

Clin Infect Dis. 2019 Oct 21. pii: ciz661. doi: 10.1093/cid/ciz661. [Epub ahead of print]

PMID:
31631215
7.

[Benzodiazepines and Z-Drugs - Analyses of Ambulatory Prescriptions from 2006 to 2015].

Verthein U, Buth S, Holzbach R, Neumann-Runde E, Martens MS.

Psychiatr Prax. 2019 Oct;46(7):399-405. doi: 10.1055/a-0961-2371. Epub 2019 Aug 14. German.

PMID:
31412372
8.

Understanding pathways to stimulant use: a mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): study protocol.

Rosenkranz M, O'Donnell A, Verthein U, Zurhold H, Addison M, Liebregts N, Rowicka M, Barták M, Petruželka B, Kaner EF, Martens MS.

BMJ Open. 2019 Aug 10;9(8):e029476. doi: 10.1136/bmjopen-2019-029476.

9.

Long-term use of benzodiazepines and Z drugs: a qualitative study of patients' and healthcare professionals' perceptions and possible levers for change.

Mokhar A, Kuhn S, Topp J, Dirmaier J, Härter M, Verthein U.

BJGP Open. 2019 Feb 20;3(1):bjgpopen18X101626. doi: 10.3399/bjgpopen18X101626. eCollection 2019 Apr.

10.

Estimation of the Number of People With Opioid Addiction in Germany.

Kraus L, Seitz NN, Schulte B, Cremer-Schaeffer P, Braun B, Verthein U, Pfeiffer-Gerschel T.

Dtsch Arztebl Int. 2019 Mar 1;116(9):137-143. doi: 10.3238/arztebl.2019.0137.

11.

Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study.

Strada L, Schmidt CS, Rosenkranz M, Verthein U, Scherbaum N, Reimer J, Schulte B.

Subst Abuse Treat Prev Policy. 2019 Jan 3;14(1):2. doi: 10.1186/s13011-018-0187-9.

12.

[Reasons for Long-Term Use of Benzodiazepines and Z-Drugs in Older Patients].

Verthein U, Kuhn S, Holzbach R, Mokhar A, Dirmaier J, Härter M, Reimer J.

Gesundheitswesen. 2019 Nov;81(11):e180-e191. doi: 10.1055/a-0719-5096. Epub 2018 Oct 24. German.

PMID:
30357800
13.

Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and z-drugs: a systematic review.

Mokhar A, Topp J, Härter M, Schulz H, Kuhn S, Verthein U, Dirmaier J.

PeerJ. 2018 Oct 8;6:e5535. doi: 10.7717/peerj.5535. eCollection 2018.

14.

Which individual, social and environmental influences shape key phases in the amphetamine type stimulant use trajectory? A systematic narrative review and thematic synthesis of the qualitative literature.

O'Donnell A, Addison M, Spencer L, Zurhold H, Rosenkranz M, McGovern R, Gilvarry E, Martens MS, Verthein U, Kaner E.

Addiction. 2019 Jan;114(1):24-47. doi: 10.1111/add.14434. Epub 2018 Oct 12. Review.

15.

Potentially inappropriate use of benzodiazepines and z-drugs in the older population-analysis of associations between long-term use and patient-related factors.

Mokhar A, Tillenburg N, Dirmaier J, Kuhn S, Härter M, Verthein U.

PeerJ. 2018 May 22;6:e4614. doi: 10.7717/peerj.4614. eCollection 2018.

16.

Development of OSTQOL: A Measure of Quality of Life for Patients in Opioid Substitution Treatment.

Strada L, Franke GH, Schulte B, Reimer J, Verthein U.

Eur Addict Res. 2017;23(5):238-248. doi: 10.1159/000484239. Epub 2017 Nov 21.

PMID:
29161720
17.

Traumatic Experiences, Revictimization and Posttraumatic Stress Disorder in German Inpatients Treated for Alcohol Dependence.

Grundmann J, Lincoln TM, Lüdecke D, Bong S, Schulte B, Verthein U, Schäfer I.

Subst Use Misuse. 2018 Mar 21;53(4):677-685. doi: 10.1080/10826084.2017.1361997. Epub 2017 Sep 27.

PMID:
28952825
18.

Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments.

Strada L, Vanderplasschen W, Buchholz A, Schulte B, Muller AE, Verthein U, Reimer J.

Qual Life Res. 2017 Dec;26(12):3187-3200. doi: 10.1007/s11136-017-1674-6. Epub 2017 Jul 31. Review.

19.

[The use of prescription drugs with dependence potential in Germany : A prospective analysis of prescriptions in the public healthcare system between 2006 and 2010].

Buth S, Holzbach R, Rosenkranz M, Verthein U.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Aug;60(8):865-872. doi: 10.1007/s00103-017-2571-4. German.

PMID:
28623381
20.

[Treatment of Alcohol Withdrawal Syndrome with Oxazepam or Clomethiazole - A Naturalistic Observational Study].

Verthein U, Kuhn S, Gabriel K, Mautsch U, Reimer J, Behrendt K.

Psychiatr Prax. 2018 Mar;45(2):95-102. doi: 10.1055/s-0042-122225. Epub 2017 Apr 3. German.

PMID:
28371954
21.

The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study.

Walcher S, Koc J, Reichel V, Schlote F, Verthein U, Reimer J.

BMC Pharmacol Toxicol. 2016 Apr 7;17:15. doi: 10.1186/s40360-016-0058-9.

22.

Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.

Strada L, Schulte B, Schmidt CS, Verthein U, Cremer-Schaeffer P, Krückeberg S, Reimer J.

BMC Infect Dis. 2015 Dec 10;15:563. doi: 10.1186/s12879-015-1307-z.

23.

Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings.

Schmidt CS, Schulte B, Seo HN, Kuhn S, O'Donnell A, Kriston L, Verthein U, Reimer J.

Addiction. 2016 May;111(5):783-94. doi: 10.1111/add.13263. Epub 2016 Jan 27. Review.

PMID:
26637990
24.

Psychosocial Determinants of Cannabis Dependence: A Systematic Review of the Literature.

Schlossarek S, Kempkensteffen J, Reimer J, Verthein U.

Eur Addict Res. 2016;22(3):131-44. doi: 10.1159/000441777. Epub 2015 Nov 10. Review.

25.

Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.

Falcato L, Beck T, Reimer J, Verthein U.

J Clin Psychopharmacol. 2015 Apr;35(2):150-7. doi: 10.1097/JCP.0000000000000288.

PMID:
25679130
26.

Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.

Verthein U, Beck T, Haasen C, Reimer J.

Eur Addict Res. 2015;21(2):97-104. doi: 10.1159/000368572. Epub 2014 Nov 22.

27.

Are experiences of sexual violence related to special needs in patients with substance use disorders? A study in opioid-dependent patients.

Schäfer I, Gromus L, Atabaki A, Pawils S, Verthein U, Reimer J, Schulte B, Martens M.

Addict Behav. 2014 Dec;39(12):1691-4. doi: 10.1016/j.addbeh.2014.07.008. Epub 2014 Jul 10.

PMID:
25117843
28.

Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.

Hämmig R, Köhler W, Bonorden-Kleij K, Weber B, Lebentrau K, Berthel T, Babic-Hohnjec L, Vollmert C, Höpner D, Gholami N, Verthein U, Haasen C, Reimer J, Ruckes C.

J Subst Abuse Treat. 2014 Oct;47(4):275-81. doi: 10.1016/j.jsat.2014.05.012. Epub 2014 Jun 10.

PMID:
25064422
29.

'South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour.

Ojha SP, Sigdel S, Meyer-Thompson HG, Oechsler H, Verthein U.

Harm Reduct J. 2014 May 23;11:17. doi: 10.1186/1477-7517-11-17.

30.

When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.

Reimer J, Boniakowski E, Bachner C, Weber B, Tietje W, Verthein U, Walcher S.

Subst Abuse Treat Prev Policy. 2014 Feb 28;9:13. doi: 10.1186/1747-597X-9-13.

31.

Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.

Beck T, Haasen C, Verthein U, Walcher S, Schuler C, Backmund M, Ruckes C, Reimer J.

Addiction. 2014 Apr;109(4):617-26. doi: 10.1111/add.12440. Epub 2014 Jan 19.

32.

Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.

Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S97-104. doi: 10.1093/cid/cit307.

PMID:
23884073
33.

Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.

Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, Reimer J.

Int J Drug Policy. 2013 Nov;24(6):e111-4. doi: 10.1016/j.drugpo.2013.04.006. Epub 2013 May 31. No abstract available.

PMID:
23726899
34.

Prevalence of problem gambling among the prison population in Hamburg, Germany.

Zurhold H, Verthein U, Kalke J.

J Gambl Stud. 2014 Jun;30(2):309-19. doi: 10.1007/s10899-013-9361-1.

PMID:
23334654
35.

[Social integration after 4 years of heroin-assisted treatment].

Verthein U, Schäfer I, Degkwitz P.

Rehabilitation (Stuttg). 2013 Aug;52(4):243-50. doi: 10.1055/s-0032-1323663. Epub 2012 Dec 11. German.

PMID:
23233342
36.

[Long-term prescription of benzodiazepines and non-benzodiazepines].

Verthein U, Martens MS, Raschke P, Holzbach R.

Gesundheitswesen. 2013 Jul;75(7):430-7. doi: 10.1055/s-0032-1321756. Epub 2012 Aug 3. German.

PMID:
22864843
37.

Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.

Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C.

Addiction. 2011 Sep;106(9):1647-55. doi: 10.1111/j.1360-0443.2011.03463.x. Epub 2011 Jul 22.

PMID:
21489005
38.

Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.

Verthein U, Haasen C, Reimer J.

Subst Use Misuse. 2011;46(8):980-91. doi: 10.3109/10826084.2010.540624. Epub 2011 Jan 14.

PMID:
21235340
39.

Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence.

Karow A, Verthein U, Pukrop R, Reimer J, Haasen C, Krausz M, Schäfer I.

Subst Use Misuse. 2011;46(6):705-15. doi: 10.3109/10826084.2010.509854. Epub 2010 Nov 3.

PMID:
21047149
40.

Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.

Karow A, Reimer J, Schäfer I, Krausz M, Haasen C, Verthein U.

Drug Alcohol Depend. 2010 Dec 1;112(3):209-15. doi: 10.1016/j.drugalcdep.2010.06.009. Epub 2010 Aug 21.

PMID:
20728288
41.

Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.

Eiroa-Orosa FJ, Haasen C, Verthein U, Dilg C, Schäfer I, Reimer J.

Drug Alcohol Depend. 2010 Dec 1;112(3):226-33. doi: 10.1016/j.drugalcdep.2010.06.013. Epub 2010 Aug 12.

PMID:
20708349
42.

Implication of gender differences in heroin-assisted treatment: results from the German randomized controlled trial.

Eiroá-Orosa FJ, Verthein U, Kuhn S, Lindemann C, Karow A, Haasen C, Reimer J.

Am J Addict. 2010 Jul-Aug;19(4):312-8. doi: 10.1111/j.1521-0391.2010.00049.x. Erratum in: Am J Addict. 2012 May-Jun;21(3):E2.

PMID:
20653637
43.

Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial.

Haasen C, Verthein U, Eiroa-Orosa FJ, Schäfer I, Reimer J.

Eur Addict Res. 2010;16(3):124-30. doi: 10.1159/000313334. Epub 2010 Apr 26.

PMID:
20424456
44.

Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.

Schulte B, Schütt S, Brack J, Isernhagen K, Deibler P, Dilg C, Verthein U, Haasen C, Reimer J.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):248-51. doi: 10.1016/j.drugalcdep.2010.01.009. Epub 2010 Feb 18.

PMID:
20167441
45.

Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.

Schäfer I, Eiroa-Orosa FJ, Verthein U, Dilg C, Haasen C, Reimer J.

Psychopathology. 2010;43(2):88-95. doi: 10.1159/000274177. Epub 2010 Jan 9.

PMID:
20068379
46.

What are the needs of alcohol dependent patients with a history of sexual violence? A case-register study in a metropolitan region.

Schäfer I, Verthein U, Oechsler H, Deneke C, Riedel-Heller S, Martens M.

Drug Alcohol Depend. 2009 Nov 1;105(1-2):118-25. doi: 10.1016/j.drugalcdep.2009.06.020. Epub 2009 Aug 3.

PMID:
19647957
47.

Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial.

Haasen C, Eiroa-Orosa FJ, Verthein U, Soyka M, Dilg C, Schäfer I, Reimer J.

Alcohol. 2009 Jun;43(4):259-64. doi: 10.1016/j.alcohol.2009.02.007. Epub 2009 Apr 17.

PMID:
19375884
48.

Explaining the effectiveness of heroin-assisted treatment on crime reductions.

Löbmann R, Verthein U.

Law Hum Behav. 2009 Feb;33(1):83-95. doi: 10.1007/s10979-008-9138-8. Epub 2008 Jul 2.

PMID:
18594954
49.

Long-term effects of heroin-assisted treatment in Germany.

Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, Köhler WK, Passie T, Soyka M, Tanger S, Vogel M, Haasen C.

Addiction. 2008 Jun;103(6):960-6; discussion 967-8. doi: 10.1111/j.1360-0443.2008.02185.x. Epub 2008 Apr 16.

PMID:
18422829
50.

Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction.

Karow A, Verthein U, Krausz M, Schafer I.

Eur Addict Res. 2008;14(1):38-46. doi: 10.1159/000110409. Epub 2008 Jan 7.

PMID:
18182771

Supplemental Content

Loading ...
Support Center